Steven M. Strasberg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Steven M. Strasberg has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Ahmed Salem
University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
1 shared publication - Bradley Aaron Krasnick
Department of Surgery, Washington University School of Medicine, St. Louis, MO
1 shared publication - Carl Richard Schmidt
West Virginia University
1 shared publication - Cecilia G. Ethun
Winship Cancer Institute, Emory University, Atlanta, Georgia
1 shared publication - Charles R. Scoggins
Division of Surgical Oncology, Hiram C. Polk Jr., M.D Department of Surgery, University of Louisville School of Medicine, Louisville, USA
1 shared publication - Chelsea A. Isom
Vanderbilt University Medical Center, Nashville, Tennessee
1 shared publication
Latest Publications
- 28 April 2021
- Published by American Medical Association (AMA) in JAMA Surgery
- Vol. 156 (8) , 795-796
Nonoperative Management for Pregnant Individuals With Gallstone Disease in the Third Trimester
To the Editor We read with interest the recent JAMA Network Insight by Schwulst and Son on the management of gallstone disease during pregnancy advocating chole
- 28 April 2021
- Published by American Medical Association (AMA) in JAMA Surgery
- Vol. 156 (8) , 795-796
Nonoperative Management for Pregnant Individuals With Gallstone Disease in the Third Trimester
To the Editor We read with interest the recent JAMA Network Insight by Schwulst and Son on the management of gallstone disease during pregnancy advocating chole
- 29 June 2020
- Published by Springer Nature in Surgical Endoscopy
- Vol. 35 (7) , 3249-3257
Less is more in the difficult gallbladder: recent evolution of subtotal cholecystectomy in a single HPB unit
Introduction Subtotal cholecystectomy (SC) is a technique to manage the difficult gallbladder and avoid hazardous dissection and biliary injury. Until recently it was used infrequently. However, because of reduced exposure to open total cholecystectomy in resident training, we recently adopted subtotal cholecystectomy as the bail-out procedure of choice for resident teaching. This study reports our experience and outcomes with subtotal cholecystectomy in the years immediately preceding adoption and since adoption. Methods A retrospective analysis was conducted of patients undergoing SC from July 2010 to June 2019. Outcomes, including bile leak, reoperation and need for additional procedures, were analyzed. Complications were graded by the Modified Accordion Grading Scale (MAGS). Results 1571 cholecystectomies were performed of which 71 were SC. Subtotal cholecystectomy patients had several indicators of difficulty including prior attempted cholecystectomy and previous cholecystostomy tube insertion. The most common indication for SC was marked inflammation in the hepatocystic triangle (51%). As our experience increased, fewer patients required open conversion to accomplish SC and SC was completed laparoscopically, usually subtotal fenestrating cholecystectomy (SFC). Most patients (85%) had a drain placed and 28% were discharged with a drain. The highest MAGS complication observed was grade 3 (11 patients, 15%). Six patients had a bile leak from the cystic duct resolved by ERCP. At mean follow-up of about 1 year no patient returned with recurrent symptoms. Conclusions Subtotal fenestrating cholecystectomy is a useful technique to avoid biliary injury in the difficult gallbladder and can be performed with very satisfactory rates of bile fistula, ERCP, and reoperation.
- 29 June 2020
- Published by Springer Nature in Surgical Endoscopy
- Vol. 35 (7) , 3249-3257
Less is more in the difficult gallbladder: recent evolution of subtotal cholecystectomy in a single HPB unit
Introduction Subtotal cholecystectomy (SC) is a technique to manage the difficult gallbladder and avoid hazardous dissection and biliary injury. Until recently it was used infrequently. However, because of reduced exposure to open total cholecystectomy in resident training, we recently adopted subtotal cholecystectomy as the bail-out procedure of choice for resident teaching. This study reports our experience and outcomes with subtotal cholecystectomy in the years immediately preceding adoption and since adoption. Methods A retrospective analysis was conducted of patients undergoing SC from July 2010 to June 2019. Outcomes, including bile leak, reoperation and need for additional procedures, were analyzed. Complications were graded by the Modified Accordion Grading Scale (MAGS). Results 1571 cholecystectomies were performed of which 71 were SC. Subtotal cholecystectomy patients had several indicators of difficulty including prior attempted cholecystectomy and previous cholecystostomy tube insertion. The most common indication for SC was marked inflammation in the hepatocystic triangle (51%). As our experience increased, fewer patients required open conversion to accomplish SC and SC was completed laparoscopically, usually subtotal fenestrating cholecystectomy (SFC). Most patients (85%) had a drain placed and 28% were discharged with a drain. The highest MAGS complication observed was grade 3 (11 patients, 15%). Six patients had a bile leak from the cystic duct resolved by ERCP. At mean follow-up of about 1 year no patient returned with recurrent symptoms. Conclusions Subtotal fenestrating cholecystectomy is a useful technique to avoid biliary injury in the difficult gallbladder and can be performed with very satisfactory rates of bile fistula, ERCP, and reoperation.
- 28 December 2017
- Published by Wiley in Journal of Surgical Oncology
- Vol. 117 (3) , 363-371
Adjuvant therapy is associated with improved survival after curative resection for hilar cholangiocarcinoma: A multi‐institution analysis from the U.S. extrahepatic biliary malignancy consortium
Background: Curative‐intent treatment for localized hilar cholangiocarcinoma (HC) requires surgical resection. However, the effect of adjuvant therapy (AT) on survival is unclear. We analyzed the impact of AT on overall (OS) and recurrence free survival (RFS) in patients undergoing curative resection.Methods: We reviewed patients with resected HC between 2000 and 2015 from the ten institutions participating in the U.S. Extrahepatic Biliary Malignancy Consortium. We analyzed the impact of AT on RFS and OS. The probability of RFS and OS were calculated in the method of Kaplan and Meier and analyzed using multivariate Cox regression analysis.Results: A total of 249 patients underwent curative resection for HC. Patients who received AT and those who did not had similar demographic and preoperative features. In a multivariate Cox regression analysis, AT conferred a significant protective effect on OS (HR 0.58, P = 0.013), and this was maintained in a propensity matched analysis (HR 0.66, P = 0.033). The protective effect of AT remained significant when node negative patients were excluded (HR 0.28, P = 0.001), while it disappeared (HR 0.76, P = 0.260) when node positive patients were excluded.Conclusions: AT should be strongly considered after curative‐intent resection for HC, particularly in patients with node positive disease.
- 28 December 2017
- Published by Wiley in Journal of Surgical Oncology
- Vol. 117 (3) , 363-371
Adjuvant therapy is associated with improved survival after curative resection for hilar cholangiocarcinoma: A multi‐institution analysis from the U.S. extrahepatic biliary malignancy consortium
Background: Curative‐intent treatment for localized hilar cholangiocarcinoma (HC) requires surgical resection. However, the effect of adjuvant therapy (AT) on survival is unclear. We analyzed the impact of AT on overall (OS) and recurrence free survival (RFS) in patients undergoing curative resection.Methods: We reviewed patients with resected HC between 2000 and 2015 from the ten institutions participating in the U.S. Extrahepatic Biliary Malignancy Consortium. We analyzed the impact of AT on RFS and OS. The probability of RFS and OS were calculated in the method of Kaplan and Meier and analyzed using multivariate Cox regression analysis.Results: A total of 249 patients underwent curative resection for HC. Patients who received AT and those who did not had similar demographic and preoperative features. In a multivariate Cox regression analysis, AT conferred a significant protective effect on OS (HR 0.58, P = 0.013), and this was maintained in a propensity matched analysis (HR 0.66, P = 0.033). The protective effect of AT remained significant when node negative patients were excluded (HR 0.28, P = 0.001), while it disappeared (HR 0.76, P = 0.260) when node positive patients were excluded.Conclusions: AT should be strongly considered after curative‐intent resection for HC, particularly in patients with node positive disease.